These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19920183)

  • 1. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
    Chen H; Zhu G; Li Y; Padia RN; Dong Z; Pan ZK; Liu K; Huang S
    Cancer Res; 2009 Dec; 69(24):9228-35. PubMed ID: 19920183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.
    Talotta F; Mega T; Bossis G; Casalino L; Basbous J; Jariel-Encontre I; Piechaczyk M; Verde P
    Oncogene; 2010 Aug; 29(33):4732-40. PubMed ID: 20543861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A JNK-independent signaling pathway regulates TNF alpha-stimulated, c-Jun-driven FRA-1 protooncogene transcription in pulmonary epithelial cells.
    Adiseshaiah P; Kalvakolanu DV; Reddy SP
    J Immunol; 2006 Nov; 177(10):7193-202. PubMed ID: 17082637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun Is Required for Nuclear Factor-κB-Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages.
    Mishra RK; Potteti HR; Tamatam CR; Elangovan I; Reddy SP
    Am J Respir Cell Mol Biol; 2016 Nov; 55(5):667-674. PubMed ID: 27286066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
    Hu L; Xia L; Zhou H; Wu B; Mu Y; Wu Y; Yan J
    Tumour Biol; 2013 Oct; 34(5):2573-81. PubMed ID: 23616010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
    Cook SJ; Aziz N; McMahon M
    Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
    Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
    BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
    Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
    Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis.
    Hanson RL; Brown RB; Steele MM; Grandgenett PM; Grunkemeyer JA; Hollingsworth MA
    Oncotarget; 2016 Jun; 7(26):39996-40011. PubMed ID: 27220889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
    Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells.
    Dai C; Zhang C; Sun X; Pan Q; Peng J; Shen J; Ma X
    Int J Biochem Cell Biol; 2016 Jul; 76():107-14. PubMed ID: 27102414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.
    McDaid HM; Horwitz SB
    Mol Pharmacol; 2001 Aug; 60(2):290-301. PubMed ID: 11455016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.
    Zhang N; Liu L; Fan N; Zhang Q; Wang W; Zheng M; Ma L; Li Y; Shi L
    Oncotarget; 2016 Sep; 7(38):61587-61600. PubMed ID: 27557506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation.
    Hurd TW; Culbert AA; Webster KJ; Tavaré JM
    Biochem J; 2002 Dec; 368(Pt 2):573-80. PubMed ID: 12197835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.